regn market cap in 2012

On December 31, 2012, Regeneron Pharmaceuticals (REGN) had a market capitalization of $19.9B, based on 117.24M shares at a price of $169.92.

DATECLOSEVOLUMEOUTSTANDINGMARKET CAP
December 31 2012
$169.92
488,100
117,237,000
$19,921,145,514.00
December 28 2012
$166.84
484,300
117,237,000
$19,560,161,067.30
December 27 2012
$167.64
750,400
117,237,000
$19,653,317,587.50
December 26 2012
$168.87
567,000
117,237,000
$19,797,718,400.40
December 24 2012
$171.88
378,400
117,237,000
$20,150,554,875.60
December 21 2012
$172.32
3,872,100
117,237,000
$20,201,799,168.30
December 20 2012
$171.68
837,600
117,237,000
$20,127,271,607.40
December 19 2012
$174.47
804,400
117,237,000
$20,454,491,798.10
December 18 2012
$178.81
695,000
117,237,000
$20,963,382,444.00
December 17 2012
$178.20
927,300
117,237,000
$20,891,187,899.40
December 14 2012
$178.50
424,700
117,237,000
$20,927,285,171.70
December 13 2012
$177.84
890,400
117,237,000
$20,849,263,948.20
December 12 2012
$181.81
554,000
117,237,000
$21,315,058,272.90
December 11 2012
$183.36
557,800
117,237,000
$21,496,728,728.10
December 10 2012
$183.45
470,100
117,237,000
$21,507,209,715.90
December 07 2012
$179.66
627,900
117,237,000
$21,062,365,643.10
December 06 2012
$180.58
801,600
117,237,000
$21,170,657,460.00
December 05 2012
$183.96
903,900
117,237,000
$21,566,590,256.40
December 04 2012
$179.49
627,500
117,237,000
$21,042,564,313.80
December 03 2012
$179.49
910,400
117,237,000
$21,042,564,313.80
November 30 2012
$175.37
2,335,300
117,237,000
$20,559,301,676.10
November 29 2012
$186.48
1,848,100
117,237,000
$21,862,379,207.40
November 28 2012
$173.74
425,300
117,237,000
$20,368,322,603.10
November 27 2012
$173.53
887,000
117,237,000
$20,343,866,964.90
November 26 2012
$173.22
816,600
117,237,000
$20,307,769,692.60